MOESM1 of Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
Bright Adu(University of Ghana), Daniel Dodoo(Commonwealth Scientific and Industrial Research Organisation), Amidou Diarra(Centre National de Recherche et de Formation sur le Paludisme), Michael Theisen(Statens Serum Institut), D. Cavanagh(Organic Research Centre), Fareed K. N. Arthur(Kwame Nkrumah University of Science and Technology), Samuel Bosomprah(Ministry of Health), Emmanuel K. Dickson(University of Ghana), Giampietro Corradin, Sodiomon B. Sirima, Issa Nebie, Mariama K. Cherif(Nazi Boni University)
Cited by 0
Related Papers
Absolute Levels and Ratios of Proinflammatory and Anti‐inflammatory Cytokine Production In Vitro Predict Clinical Immunity to<i>Plasmodium falciparum</i>Malaria
|The Journal of Infectious Diseases|2002|245
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
|Nucleic Acids Research|2019|213
<i>Plasmodium falciparum</i> Variant Surface Antigen Expression Varies Between Isolates Causing Severe and Nonsevere Malaria and Is Modified by Acquired Immunity
|The Journal of Immunology|2002|211